EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Avoiding false discoveries in single-cell RNA-seq by revisiting the first Alzheimer’s disease dataset

Alan E Murphy iD, Nurun Fancy iD, Nathan Skene

eLife · 04.12.2023 · 12

DOI: 10.7554/elife.90214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 04.12.2023. Verfasst von Alan E Murphy und 2 weiteren Autor:innen. Beteiligte Einrichtung: UK Dementia Research Institute at Imperial College London, London, United Kingdom. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Medical Research Council, UK Research and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mathys et al. conducted the first single-nucleus RNA-seq (snRNA-seq) study of Alzheimer’s disease (AD) (Mathys et al., 2019). With bulk RNA-seq, changes in gene expression across cell types can be lost, potentially masking the differentially expressed genes (DEGs) across different cell types. Through the use of single-cell techniques, the authors benefitted from increased resolution with the potential to uncover cell type-specific DEGs in AD for the first time. However, there were limitations in both their data processing and quality control and their differential expression analysis. Here, we correct these issues and use best-practice approaches to snRNA-seq differential expression, resulting in 549 times fewer DEGs at a false discovery rate of 0.05. Thus, this study highlights the impact of quality control and differential analysis methods on the discovery of disease-associated genes and aims to refocus the AD research field away from spuriously identified genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansSingle-Cell Gene Expression AnalysisQuality ControlRNA, Small NuclearRNA-Seq

Stichwörter der Autor:innen

Alzheimer's diseasechromosomesgene expressionhumanneurosciencesingle-cellsingle-nucleus

Substanzen

RNA, Small Nuclear

Autor:innen und Institutionen

  • UK Dementia Research Institute at Imperial College London, London, United Kingdom.
  • Department of Brain Sciences, Imperial College London, London, United Kingdom.

ORCID-Profile: Alan E Murphy, Nurun Fancy

Förderung

  • NIA NIH HHS
  • Medical Research Council
  • UK Research and Innovation
  • UK Dementia Research Institute

Zitieren

APA

Murphy, A. E., Fancy, N., & Skene, N. (2023). Avoiding false discoveries in single-cell RNA-seq by revisiting the first Alzheimer’s disease dataset. eLife, 12. https://doi.org/10.7554/elife.90214

Vancouver

Murphy AE, Fancy N, Skene N. Avoiding false discoveries in single-cell RNA-seq by revisiting the first Alzheimer’s disease dataset. eLife. 2023;12. doi:10.7554/elife.90214

BibTeX
@article{Murphy2023,
  author = {Murphy, Alan E and Fancy, Nurun and Skene, Nathan},
  title = {Avoiding false discoveries in single-cell RNA-seq by revisiting the first Alzheimer’s disease dataset},
  journal = {eLife},
  year = {2023},
  volume = {12},
  doi = {10.7554/elife.90214}
}
Kostenlos starten →